<p>(<b>A</b>,<b>B</b>) Analysis of IFN-γ<sup>+</sup> <i>in vitro</i> activated gBT-I (<b>A</b>,<b>B</b>) and gDT-II (<b>B</b>) T<sub>EFF</sub> cells cultured (as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004303#ppat-1004303-g005" target="_blank"><b>Figure 5</b></a>) with increasing numbers of CD45.2<sup>−</sup> and CD45.2<sup>+</sup> APCs sorted from epidermal sheets (pooled from 20 mice) 4 days after HSV-1 skin infection. Data representative (<b>A</b>) or pooled from 2–3 experiments (<b>B</b>). (<b>C</b>,<b>D</b>) Analysis of IFN-γ<sup>+</sup> <i>in vitro</i> activated gBT-I cells cultured with sorted APCs from epidermal sheets (pooled from 20 mice) 4 days after infection. APC numbers were 5×10<sup>4</...
<p>(<b>A, B</b>) <i>Ptprc<sup>L3X</sup></i> mice received 2.5×10<sup>6</sup> CD4<sup>+</sup> T cells...
(A) LCMV immune mice were infected with VacV-GP33. On day 40 post VacV-GP33 infection, mice received...
Epithelial malignancies are common in immunosuppressed individuals and the general population. Howev...
<p>(<b>A</b>,<b>B</b>) Mice were subjected to skin infection with HSV.CFP and 3 days later received ...
<p>(<b>A</b>) Mice received naïve gBT-I or gDT-II cells prior to HSV-1 skin infection and DNFB treat...
<p>(<b>A</b>) Mice received GFP<sup>+</sup> gDT-II cells prior to HSV-1 skin infection. IFM analysis...
<p>(<b>A</b>) Sorting strategy used to isolate CD11c<sup>+</sup>CD11b<sup>lo</sup> and CD11c<sup>+</...
<p>Mice received naïve gBT-I or gDT-II cells prior to HSV-1 skin infection. (<b>A</b>) Quantificatio...
<p>IFM analysis of skin, 5 (<b>A</b>,<b>D</b>), 6 (<b>C</b>) and 8 (<b>B</b>) days post-infection, s...
Efficient infection control requires potent T-cell responses at sites of pathogen replication. Howev...
<div><p>Efficient infection control requires potent T-cell responses at sites of pathogen replicatio...
© 2014 Dr. Bethany Lee MacleodT cell priming by professional antigen presenting cells (APCs) has tra...
<p>C57BL/6 mice infected with HSV-1 were treated with various concentrations of FTY720 or vehicle 24...
Efficient infection control requires potent T-cell responses at sites of pathogen replication. Howev...
Inflammasomes are immune complexes, which induce an inflammatory response upon sensing of different ...
<p>(<b>A, B</b>) <i>Ptprc<sup>L3X</sup></i> mice received 2.5×10<sup>6</sup> CD4<sup>+</sup> T cells...
(A) LCMV immune mice were infected with VacV-GP33. On day 40 post VacV-GP33 infection, mice received...
Epithelial malignancies are common in immunosuppressed individuals and the general population. Howev...
<p>(<b>A</b>,<b>B</b>) Mice were subjected to skin infection with HSV.CFP and 3 days later received ...
<p>(<b>A</b>) Mice received naïve gBT-I or gDT-II cells prior to HSV-1 skin infection and DNFB treat...
<p>(<b>A</b>) Mice received GFP<sup>+</sup> gDT-II cells prior to HSV-1 skin infection. IFM analysis...
<p>(<b>A</b>) Sorting strategy used to isolate CD11c<sup>+</sup>CD11b<sup>lo</sup> and CD11c<sup>+</...
<p>Mice received naïve gBT-I or gDT-II cells prior to HSV-1 skin infection. (<b>A</b>) Quantificatio...
<p>IFM analysis of skin, 5 (<b>A</b>,<b>D</b>), 6 (<b>C</b>) and 8 (<b>B</b>) days post-infection, s...
Efficient infection control requires potent T-cell responses at sites of pathogen replication. Howev...
<div><p>Efficient infection control requires potent T-cell responses at sites of pathogen replicatio...
© 2014 Dr. Bethany Lee MacleodT cell priming by professional antigen presenting cells (APCs) has tra...
<p>C57BL/6 mice infected with HSV-1 were treated with various concentrations of FTY720 or vehicle 24...
Efficient infection control requires potent T-cell responses at sites of pathogen replication. Howev...
Inflammasomes are immune complexes, which induce an inflammatory response upon sensing of different ...
<p>(<b>A, B</b>) <i>Ptprc<sup>L3X</sup></i> mice received 2.5×10<sup>6</sup> CD4<sup>+</sup> T cells...
(A) LCMV immune mice were infected with VacV-GP33. On day 40 post VacV-GP33 infection, mice received...
Epithelial malignancies are common in immunosuppressed individuals and the general population. Howev...